The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizationsDonald S. Silverberg, Adrian Iaina, Dov Wexler et al.|Journal of the American College of Cardiology|2000Cited by 729
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled studyDonald S. Silverberg, Adrian Iaina, Dov Wexler et al.|Journal of the American College of Cardiology|2001Cited by 645
Randomised crossover trial of naltrexone in uraemic pruritusGary Peer, Adrian Iaina, Miriam Blum et al.|The Lancet|1996Cited by 298
Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysisDonald S. Silverberg, Miriam Blum, Adrian Iaina et al.|American Journal of Kidney Diseases|1996Cited by 176
The association between congestive heart failure and chronic renal diseaseDonald S. Silverberg, Adrian Iaina, Dov Wexler et al.|Current Opinion in Nephrology & Hypertension|2004Cited by 174